Endoscopic Ultrasound (EUS) Fine Needle Biopsy (FNB) Submucosal Nodule
Status: | Recruiting |
---|---|
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 10/24/2018 |
Start Date: | September 5, 2017 |
End Date: | September 2019 |
Contact: | Tina Lucas |
Email: | tina.lucas@duke.edu |
Phone: | 919 668 1679 |
Endoscopic Ultrasound Fine Needle Biopsy of Submucosal Lesions of the GI Tract; Finding the Right Needle - A Randomized Study
The purpose of this study is to compare the diagnostic accuracy of a novel endoscopic
ultrasound (EUS) biopsy needle to the current standard EUS needle.
The investigators hypothesize that with the SharkcoreTM needle a diagnostic yield of 90% is
possible for subepithelial lesions (SEL) within the Gastrointestinal (GI) tract versus 60%
yield with the current needle.
ultrasound (EUS) biopsy needle to the current standard EUS needle.
The investigators hypothesize that with the SharkcoreTM needle a diagnostic yield of 90% is
possible for subepithelial lesions (SEL) within the Gastrointestinal (GI) tract versus 60%
yield with the current needle.
Inclusion Criteria:
- Patients age 18 or older referred for EUS found to have a hypoechoic lesion > 8 mm
within the GI lumen arising from the muscularis propria, as determined by EUS.
- Women that have a negative pregnant test
Exclusion Criteria:
- Patients under the age of 18.
- Uncorrectable coagulopathy (INR>1.5)
- Uncorrectable thrombocytopenia (platelet count <50,000)
- Patient who is unable to comply with study requirements
- Pregnant women
- Female patients who are not tested per our current unit protocol
- Refusal to consent or unable to provide informed consent
We found this trial at
1
site
Click here to add this to my saved trials